Consolidated Statement Of Comprehensive Income

Carna Biosciences, Inc. - Filing #7595165

Concept 2022-01-01 to
2022-06-30
2021-01-01 to
2021-06-30
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-359,120,000 JPY
-776,472,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-1,241,000 JPY
-292,000 JPY
Deferred gains or losses on hedges
87,600,000 JPY
1,963,000 JPY
Foreign currency translation adjustment
36,662,000 JPY
9,221,000 JPY
Other comprehensive income
123,021,000 JPY
10,892,000 JPY
Comprehensive income
-236,098,000 JPY
-765,579,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-236,098,000 JPY
-765,579,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.